N/A N=1,212 Disrupt CAD III Post-Approval Study (PAS)
Coronary Artery Disease · Myocardial Infarction
Primary: All-cause Death Rate — 3 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=47 The Families Addressing Cancer Together Intervention for Parents With Cancer
Neoplasms · Cancer · Parenting
Primary: Families Addressing Cancer Together (FACT) Satisfaction Scale — 16.24 score on a scale
N/A N=133 Shared Medical Decision Making in Pediatric Diabetes
Type 1 Diabetes Mellitus
Primary: Continuous Glucose Monitor Use Profile or Insulin Pump Use Profile — 32.5; 34.2; 40.1; 35.7 score on a scale — p=<0.39
Phase 3 N=416 Hydrochlorothiazide for Kidney Stone Recurrence Prevention
Nephrolithiasis
Primary: Number of Participants With Stone Recurrences — 60; 62; 61; 49 Participants
N/A N=201 Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents
Cannabis Use · Cognitive Change · Adolescent Behavior
Primary: Mean Difference in the Total Number of Errors From Paired Associates Learning (PAL) Module Averaged Over Weeks 1, 2, 3, and 4 — 5.6; 6.2; 5.9 score on a scale — p=0.215
N/A N=47 Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
Major Depressive Disorder
Primary: Total Children's Depression Rating Scale, Revised (CDRS-R) Score — 41.768; 44.541 score on a scale
N/A N=17 Heated Vest for Persons With Spinal Cord Injury
Spinal Cord Injuries
Primary: Change in Core Body Temperature (Tcore) — -0.22; -0.46 Degrees Celsius — p=<0.05
Phase 3 N=183 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Acne Vulgaris
Primary: Absolute Change From Baseline to Week 12 in Inflammatory Lesion Counts — -27.7; -21.7 lesion counts
N/A N=25 WREX Outcome Study
Muscular Dystrophy · Arthrogryposis · Spinal Muscular Atrophy
Primary: Canadian Occupational Performance Measure (COPM) — 7.09 score on a scale
Phase 3 N=180 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Acne Vulgaris
Primary: Absolute Change From Baseline to Week 12 in Inflammatory Lesion Counts — -30.1; -20.8 lesion counts
Phase 2 N=80 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
Venous Thromboembolism · Deep Vein Thrombosis · Pulmonary Embolus
Primary: Number of Participants With Venous Thromboembolism Events — 1 Participants
N/A N=77,145 Effectiveness and Implementation of mPATH-CRC
Colorectal Cancer · Cancer · Rectum Cancer
Primary: Percent of Patients Who Complete the mPATH-CRC Program — 5; 4 Participants
Phase 2 N=29 Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
Cystic Fibrosis · Pseudomonas Aeruginosa · Pseudomonas
Primary: Incidence and Severity Treatment Emergent Adverse Events (TEAEs) — 1; 1; 1; 0 Participants
Phase 2 N=87 A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
Adenoid Cystic Carcinoma
Primary: Overall Response Rate (ORR) — 3; 2 Participants
N/A N=6 Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder (Pilot Study)
Cocaine Use Disorder
Primary: Amplitude of the Reward Potential (RewP) in Microvolts in Response to Feedback on the Doors Task as Assessed by EEG — -1.09; 0.61; -0.23; 0.12 microvolts